| Competitors: | Venn Life Sciences Holdings, Circle Holdings , Diaceutics , Sourcebio International, CareTech Holding, Trellus Health, Mediclinic International , Sensyne Health, Tristel |
| CEO: | Rob Baker |
| CFO: | Ronald Openshaw |
| Independent Non-Executive Director: | Stuart Gall |
| Independent Non-Executive Director: | Jon Kempster |
| Non-Executive Dir: | Nick (Philip) Rodgers |
| Address: | Tunbridge Court,Tunbridge Lane,Bottisham Cambridge,United Kingdom, CB25 9TU |
| Phone: | +44 (0)1223 810700 |
| Website: | http://www.cambridgecognition.com/ |
| Sector: | Health Care(LSE) |
| Index: | FTSE AIM All-Share |
| ISIN: | GB00B8DV9647 |
| Currency | UK Pounds |
| Share Price | 33.00p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 43.50 |
| 52 Week Low | 25.00 |
| Volume | 15,324 |
| Shares Issued | 54.04m |
| Market Cap | £17.83m |
| Beta | 0.00 |
| RiskGrade | 282 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 15:17 | 85 @ 34.00p |
| 15:17 | 1 @ 34.00p |
| 15:17 | 5 @ 34.00p |
| 15:17 | 80 @ 34.00p |
| 08:29 | 15,000 @ 32.00p |
| CEO | Rob Baker |
| CFO | Ronald Openshaw |
You are here: research